University Spin-Off Virmedex Expands Internationally and Prepares New Funding Round
Rapid adoption across United States medical programs validates the cloud educational model, paving the way for a Series A round.
BARCELONA / NEW YORK //
Institutional channels have confirmed the robust international commercial expansion of Virmedex.
The platform has achieved exceptional growth in software license adoption across clinical perfusion schools and surgical departments in both Europe and the United States.
Following this strong market validation, the board has initiated strategic preparations to open a Series A investment round in mid-2026 to fuel further product scaling.
More news
Virmedex: When Video Games Save Lives in the Operating Room
Specialist portal Aware.Doctor analyzes Virmedex's brand identity, 3D design language, and its educational philosophy of building resilience through controlled mistakes in virtual environments.
Read the article →
Virmedex Awarded the City of Barcelona Prize for Applied Innovation
Academic and public media celebrate Virmedex receiving the City of Barcelona Prize for its outstanding achievements in applied technological innovation within the healthcare sector.
Read the article →
Rapid adoption across United States medical programs validates the cloud educational model, paving the way for a Series A round.
Virmedex announces the growth of its software subscriptions in European hospitals and US universities, moving forward with strategic preparations to open a second funding round in mid-2026.
Read the article →